ml 9 has been researched along with ml 7 in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (39.13) | 18.2507 |
| 2000's | 11 (47.83) | 29.6817 |
| 2010's | 3 (13.04) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerena, L; Geyer, JA; Keenan, SM; Waters, NC; Welsh, WJ; Woodard, CL | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Grütter, C; Heynck, S; Rauh, D; Rode, HB; Simard, JR; Sos, ML | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Isemura, M; Mita, T; Motomiya, M; Narumi, K; Satoh, K | 1 |
| Hattori, M; Honma, Y; Hozumi, M; Makishima, M; Motoyoshi, K; Sampi, K | 1 |
| Badwey, JA; Curnutte, JT; Ding, J; Erickson, RW; Heyworth, PG | 1 |
| Honma, Y; Hozumi, M; Makishima, M; Motoyoshi, K; Nagata, N | 1 |
| Aussel, C; Breittmayer, JP; Dumaurier, MJ; Marhaba, R; Pelassy, C | 1 |
| Puschner, B; Schacht, J | 1 |
| Ando, J; Goto, Y; Hayashi, H; Hidaka, H; Isshiki, M; Niki, I; Ohno, R; Seto, M; Takahashi, R; Watanabe, H; Zhang, XX | 1 |
| Hoffmann, EK; Jakobsen, LD; Jensen, BS; Krarup, T | 1 |
| Kimura, T; Kuwashima, H; Matsumura, C | 1 |
| Dunham, PB; Kelley, SJ; Thomas, R | 1 |
| Kaneko, K; Masamune, A; Satoh, A; Satoh, K; Shimosegawa, T | 1 |
| Forer, A; Silverman-Gavrila, RV | 1 |
| Boccacci, GL; Correale, J; Santa Coloma, TA; Thomas, MG | 1 |
| Bain, J; Cohen, P; Elliott, M; McLauchlan, H | 1 |
| Jiraviriyakul, A; Phattarasakul, K; Sutthiphongchai, T; Tohtong, R | 1 |
| Connell, LE; Helfman, DM | 1 |
| Inoue, R; Ito, Y; Jin, XH; Li, YQ; Mori, Y; Shi, J; Takahashi, S | 1 |
| Cao, C; Lin, H; Pallone, TL | 1 |
| Butler, TM; Siegman, MJ | 1 |
23 other study(ies) available for ml 9 and ml 7
| Article | Year |
|---|---|
Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase Pfmrk.
Topics: Animals; Binding Sites; Crystallography, X-Ray; Cyclic AMP-Dependent Protein Kinases; Cyclin-Dependent Kinases; Drug Evaluation, Preclinical; Enzyme Inhibitors; Inhibitory Concentration 50; Ligands; Malaria; Molecular Conformation; Naphthalenes; Plasmodium falciparum; Sulfonamides | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Synthesis and biological evaluation of 7-substituted-1-(3-bromophenylamino)isoquinoline-4-carbonitriles as inhibitors of myosin light chain kinase and epidermal growth factor receptor.
Topics: Adenosine Triphosphate; ErbB Receptors; Humans; Isoquinolines; Models, Molecular; Myosin-Light-Chain Kinase; Protein Kinase Inhibitors; Structure-Activity Relationship | 2011 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Myosin light chain kinase inhibitors ML-7 and ML-9 inhibit mouse lung carcinoma cell attachment to the fibronectin substratum.
Topics: Animals; Azepines; Calmodulin; Cell Adhesion; Cell Line; Fibronectins; Mice; Myosin-Light-Chain Kinase; Naphthalenes; Polylysine; Sulfonamides | 1991 |
Induction of differentiation of human leukemia cells by inhibitors of myosin light chain kinase.
Topics: Azepines; Cell Differentiation; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Promyelocytic, Acute; Muramidase; Myosin-Light-Chain Kinase; Naphthalenes; Nitroblue Tetrazolium; Oxidation-Reduction; Tumor Cells, Cultured | 1991 |
Naphthalenesulphonamides block neutrophil superoxide production by intact cells and in a cell-free system: is myosin light chain kinase responsible for these effects?
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Azepines; Cell-Free System; Enzyme Inhibitors; Guinea Pigs; Humans; Isoquinolines; Myosin-Light-Chain Kinase; Naphthalenes; Neutrophils; Octoxynol; Piperazines; Sulfonamides; Superoxides; Tetradecanoylphorbol Acetate | 1995 |
Differentiation of human monoblastic leukemia U937 cells induced by inhibitors of myosin light chain kinase and prevention of differentiation by granulocyte-macrophage colony-stimulating factor.
Topics: Azepines; Cell Differentiation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Myosin-Light-Chain Kinase; Naphthalenes; Signal Transduction; Tumor Cells, Cultured | 1993 |
Regulation of phospholipid biosynthesis by Ca(2+)-calmodulin-dependent protein kinase inhibitors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Arachidonic Acid; Azepines; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carbazoles; Endoplasmic Reticulum; Enzyme Inhibitors; Humans; Indoles; Jurkat Cells; Myosin-Light-Chain Kinase; Naphthalenes; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylserines; Phospholipids | 1997 |
Calmodulin-dependent protein kinases mediate calcium-induced slow motility of mammalian outer hair cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Animals; Azepines; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cell Movement; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guinea Pigs; Hair Cells, Auditory, Outer; Ionomycin; Ionophores; Isoquinolines; Myosin-Light-Chain Kinase; Naphthalenes; Phosphorylation; Staurosporine; Sulfonamides | 1997 |
An essential role of myosin light-chain kinase in the regulation of agonist- and fluid flow-stimulated Ca2+ influx in endothelial cells.
Topics: Animals; Azepines; Bradykinin; Calcium; Calcium Channel Agonists; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Molecular Structure; Myosin Light Chains; Myosin-Light-Chain Kinase; Naphthalenes; Phosphorylation; Protein Kinase Inhibitors; Swine; Thapsigargin | 1998 |
Na+-K+-2Cl- cotransport in Ehrlich cells: regulation by protein phosphatases and kinases.
Topics: Animals; Azepines; Bradykinin; Carbazoles; Carcinoma, Ehrlich Tumor; Carrier Proteins; Chlorides; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Homeostasis; Hypertonic Solutions; Indoles; Isoquinolines; Kinetics; Marine Toxins; Mice; Myosin-Light-Chain Kinase; Naphthalenes; Osmolar Concentration; Oxazoles; Phosphoprotein Phosphatases; Potassium; Protein Kinases; Pyrroles; Sodium-Potassium-Chloride Symporters; Sulfonamides; Tumor Cells, Cultured | 1998 |
Myosin light chain kinase inhibitors and calmodulin antagonist inhibit Ca(2+)- and ATP-dependent catecholamine secretion from bovine adrenal chromaffin cells.
Topics: Acetylcholine; Adenosine Triphosphate; Adrenal Glands; Animals; Azepines; Calcium; Calmodulin; Catecholamines; Cattle; Cell Membrane Permeability; Cells, Cultured; Chromaffin Cells; Dose-Response Relationship, Drug; Enzyme Inhibitors; Escin; Exocytosis; Myosin-Light-Chain Kinase; Naphthalenes; Potassium; Trifluoperazine | 1999 |
Candidate inhibitor of the volume-sensitive kinase regulating K-Cl cotransport: the myosin light chain kinase inhibitor ML-7.
Topics: Adult; Alkaloids; Androstadienes; Animals; Azepines; Calcimycin; Calcium; Carbazoles; Carrier Proteins; Cell Size; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythrocytes; Humans; Indoles; K Cl- Cotransporters; Magnesium; Myosin-Light-Chain Kinase; Naphthalenes; Sheep; Staurosporine; Symporters; Wortmannin | 2000 |
Myosin light chain kinase inhibitors can block invasion and adhesion of human pancreatic cancer cell lines.
Topics: Azepines; Cell Adhesion; Cell Movement; Cell Survival; Enzyme Inhibitors; Humans; Integrin beta1; Myosin-Light-Chain Kinase; Naphthalenes; Neoplasm Invasiveness; Neoplasm Metastasis; Pancreatic Neoplasms; Tumor Cells, Cultured | 2002 |
Effects of anti-myosin drugs on anaphase chromosome movement and cytokinesis in crane-fly primary spermatocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Anaphase; Animals; Azepines; Cell Division; Chromosomes; Diacetyl; Dimethyl Sulfoxide; Diptera; Male; Meiosis; Microscopy, Phase-Contrast; Myosins; Naphthalenes; Sex Chromosomes; Spermatocytes; Testis | 2001 |
Myosin light chain kinase inhibitors induce retraction of mature oligodendrocyte processes.
Topics: Animals; Azepines; Enzyme Inhibitors; Myosin-Light-Chain Kinase; Naphthalenes; Oligodendroglia; Phosphorylation; Rats; Rats, Wistar | 2002 |
The specificities of protein kinase inhibitors: an update.
Topics: Alkaloids; Anthracenes; Azepines; Benzazepines; Carbazoles; Catechin; Cyclin-Dependent Kinases; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Indoles; JNK Mitogen-Activated Protein Kinases; Kinetin; Mitogen-Activated Protein Kinases; Naphthalenes; Oximes; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyrimidines; Signal Transduction; src-Family Kinases; Substrate Specificity | 2003 |
Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chain.
Topics: Adenocarcinoma; Animals; Azepines; Cell Division; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Male; Methotrexate; Myosin Light Chains; Myosin-Light-Chain Kinase; Naphthalenes; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Prostatic Neoplasms; Rats | 2003 |
Myosin light chain kinase plays a role in the regulation of epithelial cell survival.
Topics: Amides; Azepines; Cell Line; Cell Line, Transformed; Cell Survival; Cells, Cultured; Epithelial Cells; Humans; Integrin beta1; Intracellular Signaling Peptides and Proteins; Myosin Type II; Myosin-Light-Chain Kinase; Naphthalenes; Protein Serine-Threonine Kinases; Pyridines; rho-Associated Kinases; Signal Transduction | 2006 |
Myosin light chain kinase-independent inhibition by ML-9 of murine TRPC6 channels expressed in HEK293 cells.
Topics: Androstadienes; Animals; Azepines; Carbachol; Cell Line; Diglycerides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Membrane Potentials; Mice; Mutation; Myosin-Light-Chain Kinase; Naphthalenes; Patch-Clamp Techniques; Peptide Fragments; Transfection; TRPC Cation Channels; TRPC6 Cation Channel; Wortmannin | 2007 |
Murine vasa recta pericyte chloride conductance is controlled by calcium, depolarization, and kinase activity.
Topics: Angiotensin II; Animals; Azepines; Benzylamines; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Chlorides; Ion Transport; Juxtaglomerular Apparatus; Membrane Potentials; Mice; Mice, Inbred C57BL; Microvessels; Myosin-Light-Chain Kinase; Naphthalenes; Patch-Clamp Techniques; Pericytes; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Sulfonamides; Time Factors | 2010 |
A force-activated kinase in a catch smooth muscle.
Topics: Animals; Azepines; Muscle, Smooth; Myosin Light Chains; Myosin-Light-Chain Kinase; Mytilus edulis; Naphthalenes; Phosphorylation; Protein Kinase Inhibitors; Structure-Activity Relationship | 2011 |